基底细胞癌核心结局指标集的制定
针对基底细胞癌临床研究结局报告存在变异的问题,通过患者与专业人员的德尔菲流程及共识会议,从235个候选结局中筛选出5个核心结局:完全缓解、持续或严重不良事件、无复发生存、生活质量及患者满意度(含美容效果)。
要点
- 基底细胞癌核心结局集包含完全缓解、持续或严重不良事件、无复发生存、生活质量和患者满意度(含美容效果)。
- 候选结局经系统文献综述和关键利益相关者调查确定235个,两轮德尔菲评估74个。
- 100名卫生保健专业人员和患者参与德尔菲评分,27个结局获临时接受。
核心结论
- 已制定基底细胞癌核心结局集,使用相关测量可能提高临床研究效用和治疗指南质量。
研究设计与样本
- 患者与专业人员德尔菲流程筛选长列表,最终举行共识会议。
- 系统文献综述和关键利益相关者调查确定235个候选结局。
- 100名卫生保健专业人员和患者参与两轮德尔菲评分。
主要发现
- 235个候选结局经筛选后74个由100名卫生保健专业人员和患者在2轮德尔菲中评分。
- 27个结局获临时接受。
- 共识会议后最终核心集包含5个结局:完全缓解;持续或严重不良事件;无复发生存;生活质量;患者满意度(含美容效果)。
关键数值与推荐
- 结局需被每个利益相关者组70%的成员评为重要(评分7-9分,9分为最高)方可获临时接受。
临床怎么用
- 原文未据此给出推荐。
局限性
- 英语患者和专业人员对从英语语言研究中提取的结局进行评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is variation in the outcomes reported in clinical studies of basal cell carcinoma. This can prevent effective meta-analyses from answering important clinical questions. OBJECTIVE: To identify a recommended minimum set of core outcomes for basal cell carcinoma clinical trials. METHODS: Patient and professional Delphi process to cull a long list, culminating in a consensus meeting. To be provisionally accepted, outcomes needed to be deemed important (score, 7-9, with 9 being the maximum) by 70% of each stakeholder group. RESULTS: Two hundred thirty-five candidate outcomes identified via a systematic literature review and survey of key stakeholders were reduced to 74 that were rated by 100 health care professionals and patients in 2 Delphi rounds. Twenty-seven outcomes were provisionally accepted. The final core set of 5 agreed-upon outcomes after the consensus meeting included complete response; persistent or serious adverse events; recurrence-free survival; quality of life; and patient satisfaction, including cosmetic outcome. LIMITATIONS: English-speaking patients and professionals rated outcomes extracted from English language studies. CONCLUSION: A core outcome set for basal cell carcinoma has been developed. The use of relevant measures may improve the utility of clinical research and the quality of therapeutic guidance available to clinicians.
引用
- Schlessinger DI, Reynolds KA, Dirr MA, et al. Development of a core outcome set for basal cell carcinoma. J Am Acad Dermatol. 2022. PMID: 35551965. doi:10.1016/j.jaad.2022.04.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。